The importance of using appropriate malaria chemoprophylaxis is being emphasised by the CDCInpharma Weekly -doi:10.2165/00128413-200113000-00010NoneSpringer International PublishingInpharma Weekly
ovale malaria; presumptive anti-relapse therapy (PART; terminal prophylaxis) in persons with extensive exposure to these parasites; and primary prophylaxis against all malaria species. All persons for whom primaquine is being considered must have a glucose-6-phosphate dehydrogenase (G6PD) enzyme level ...